7427 Share Price Performance
NT$31.00
-4.00 (-11.43%)
Price NT$31.00
Share PriceNT$31.00
Great Novel Therapeutics Biotech & Medicals Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
7427 Community Narratives
There are no narratives available yet.
Recent 7427 News & Updates
Great Novel Therapeutics Biotech & Medicals Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -2.04
- Gross Margin
- 59.80%
- Net Profit Margin
- -4,927.12%
- Debt/Equity Ratio
- 0%
Great Novel Therapeutics Biotech & Medicals Competitors
Snowflake Analysis
About 7427
- Founded
- 2013
- Employees
- 15
- CEO
- WebsiteView website
Great Novel Therapeutics Biotech & Medicals engages in the development of drugs for the treatment of advanced and refractory cancers. It develops drugs for cancer immunotherapy, including tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was formerly known as GNT Biotech & Medicals Corporation. Great Novel Therapeutics Biotech & Medicals was founded in 2013 and is based in Taipei City, Taiwan.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Taiwanese Market Performance
- 7 Days: 4.4%
- 3 Months: 18.2%
- 1 Year: 18.0%
- Year to Date: 16.2%
Over the last 7 days, the market has risen 4.4%, driven by gains of 6.3% in the Information Technology sector. As for the past 12 months, the market is up 18%. Looking forward, earnings are forecast to grow by 18% annually. Market details ›